Linked Data API

Show Search Form

Search Results

1121453
star this property registered interest false more like this
star this property date less than 2019-04-11more like thismore than 2019-04-11
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Vaccination: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what steps his Department is taking to stimulate research and development into vaccines, including for tuberculosis, as an alternative to antibiotics. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 244039 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-04-24
star this property answer text <p>The United Kingdom national action plan on antimicrobial resistance (AMR), published on 24 January 2019, contains the commitment to continue to support research into new and alternative treatments, vaccines and diagnostic tests.</p><p>The Government has invested over £350 million in AMR research and development since 2014, including research funding calls with vaccination in scope, most recently the £32 million capital funding call lead by the National Institute for Health Research (NIHR), and the Small Business Research Initiative competition which announced its awards in January 2019. We would expect to consider the role of vaccines for AMR in future programmatic funding.</p><p>The UK supports the development of vaccines through UK Aid programmes such as the Global AMR Innovation Fund (GAMRIF) and the UK Vaccine Network. GAMRIF is a £50 million fund to support innovative research and development for AMR, for the benefit of people in low- and middle-income countries, and invests £30 million into preventative measures in human and animal health, including vaccines for AMR not including tuberculosis (TB). The fund includes a £1 million work package with the Bacterial Vaccinology Network which supports early stage research and development around the world to drive the development and uptake of vaccines for AMR in humans and animals.</p><p>The UK supports TB vaccine research through the Medical Research Council (MRC), with support to the European and Developing Countries Clinical Trials Partnership, and through the Joint Global Health Clinical Trials programme represented by the Department for International Development (DFID), MRC, NIHR and Wellcome. DFID’s Agriculture research team is supporting work on bovine TB vaccine development in partnership with the Bill and Melinda Gates Foundation.</p><p> </p>
star this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 244040 more like this
star this property question first answered
less than 2019-04-24T08:08:02.973Zmore like thismore than 2019-04-24T08:08:02.973Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1121454
star this property registered interest false more like this
star this property date less than 2019-04-11more like thismore than 2019-04-11
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Vaccination: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what funding he plans to make to stimulate research and development into vaccines as an alternative to antibiotics. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 244040 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-04-24
star this property answer text <p>The United Kingdom national action plan on antimicrobial resistance (AMR), published on 24 January 2019, contains the commitment to continue to support research into new and alternative treatments, vaccines and diagnostic tests.</p><p>The Government has invested over £350 million in AMR research and development since 2014, including research funding calls with vaccination in scope, most recently the £32 million capital funding call lead by the National Institute for Health Research (NIHR), and the Small Business Research Initiative competition which announced its awards in January 2019. We would expect to consider the role of vaccines for AMR in future programmatic funding.</p><p>The UK supports the development of vaccines through UK Aid programmes such as the Global AMR Innovation Fund (GAMRIF) and the UK Vaccine Network. GAMRIF is a £50 million fund to support innovative research and development for AMR, for the benefit of people in low- and middle-income countries, and invests £30 million into preventative measures in human and animal health, including vaccines for AMR not including tuberculosis (TB). The fund includes a £1 million work package with the Bacterial Vaccinology Network which supports early stage research and development around the world to drive the development and uptake of vaccines for AMR in humans and animals.</p><p>The UK supports TB vaccine research through the Medical Research Council (MRC), with support to the European and Developing Countries Clinical Trials Partnership, and through the Joint Global Health Clinical Trials programme represented by the Department for International Development (DFID), MRC, NIHR and Wellcome. DFID’s Agriculture research team is supporting work on bovine TB vaccine development in partnership with the Bill and Melinda Gates Foundation.</p><p> </p>
star this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 244039 more like this
star this property question first answered
less than 2019-04-24T08:08:03.02Zmore like thismore than 2019-04-24T08:08:03.02Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this